Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 May 8:15:1421500.
doi: 10.3389/fgene.2024.1421500. eCollection 2024.

Editorial: Epigenetic biomarkers for cancer risk stratification and patient management

Miljana Tanić  1   2 , Simone Ecker  2 , Iben Lyskjær  2   3
Affiliations
Editorial

Editorial: Epigenetic biomarkers for cancer risk stratification and patient management

Miljana Tanić et al. Front Genet. .
No abstract available

Keywords: DNA methylation; RNA modifications; biomarkers; cancer; chromatine; epidemiology; epigenetics.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Epigenetic biomarkers for cancer risk stratification and patient management

References

    1. Berdasco M., Esteller M. (2019). Clinical epigenetics: seizing opportunities for translation. Nat. Rev. Genet. 20 (2), 109–127. 10.1038/s41576-018-0074-2 - DOI - PubMed
    1. Jones P. A., Baylin S. B. (2002). The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3 (6), 415–428. 10.1038/nrg816 - DOI - PubMed
    1. Widschwendter M., Jones A., Evans I., Reisel D., Dillner J., Sundstrom K., et al. (2018). Epigenome-based cancer risk prediction: rationale, opportunities and challenges. Nat. Rev. Clin. Oncol. 15 (5), 292–309. 10.1038/nrclinonc.2018.30 - DOI - PubMed
    1. Zhao S., Allis C. D., Wang G. G. (2021). The language of chromatin modification in human cancers. Nat. Rev. Cancer 21 (7), 413–430. 10.1038/s41568-021-00357-x - DOI - PMC - PubMed

Publication types

LinkOut - more resources